Este articulo es un Preprint
Los preprints son informes de investigación preliminares que no han sido certificados por revisión por pares. No deben considerarse para guiar la práctica clínica o los comportamientos relacionados con la salud y no deben publicarse en los medios como información establecida.
Los preprints publicados en línea permiten a los autores recibir comentarios rápidamente, y toda la comunidad científica puede evaluar de forma independiente el trabajo y responder adecuadamente. Estos comentarios se publican junto con los preprints para que cualquiera pueda leer y servir como una revisión pospublicación.
Superspreading event of COVID-19 in adolescents: is there a difference between the vaccinated and the unvaccinated?
SciELO Preprints; nov. 2021.
Preprint
en En
| PREPRINT-SCIELO
| ID: pps-3134
Biblioteca responsable:
BR1.1
ABSTRACT
Objective:
The aim of this study is to estimate the incidence of COVID-19 in a vaccinated and an unvaccinated group of adolescents and describe their symptoms.Methods:
In May 2021 a private indoor event for high school adolescents took place resulting in a superspreading event. As part of the study, an anonymous questionnaire was sent to all adolescents invited to the event and details about symptoms, previous COVID-19 infection, vaccination status and behaviour during the event was assessed. Two groups were formed, one of vaccinated individuals and the other of unvaccinated individuals. A sample from a fully vaccinated symptomatic individual was sequenced. General characteristics for the studied groups are described using categorical and continuous data. The incidence of COVID-19 in each group was estimated by taking the total number of COVID-19 positive cases (numerator) divided by the total number of individuals (denominator) multiplied by 100.Results:
A total of 41 out of the 164 adolescents (incidence 25%, 95%CI 18.6- 32.4) that attended the private indoor event developed COVID-19. A sample was sequenced from one of the symptomatic and fully vaccinated individuals with BNT162b2 (Pfizer-BioNTech vaccine) finding SARS-CoV-2 Delta (B.1.617.2) variant of concern. The incidence of COVID-19 in the unvaccinated was 35.1% (95%CI 25.5-45.6), and in the vaccinated 11.4% (95%CI 5.1-21.3). There were more unvaccinated than vaccinated teenagers that developed COVID-19
Texto completo:
1
Colección:
09-preprints
Base de datos:
PREPRINT-SCIELO
Idioma:
En
Año:
2021
Tipo del documento:
Preprint